These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 8649778

  • 1. Synergism between two growth regulatory pathways: cooperative transformation of NIH3T3 cells by G alpha 12 and c-raf-1.
    Zhang Y, Saez R, Leal MA, Chan AM.
    Oncogene; 1996 Jun 06; 12(11):2377-83. PubMed ID: 8649778
    [Abstract] [Full Text] [Related]

  • 2. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M, Kishida S, Murai H, Hinoi T, Kikuchi A.
    Cancer Res; 1996 May 15; 56(10):2387-92. PubMed ID: 8625316
    [Abstract] [Full Text] [Related]

  • 3. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV, Reynolds ER, Shao H, Grana TM, Chan TO, Andres DA, Cox AD.
    Oncogene; 2000 Sep 28; 19(41):4685-94. PubMed ID: 11032018
    [Abstract] [Full Text] [Related]

  • 4. smg/rap1/Krev-1 p21s inhibit the signal pathway to the c-fos promoter/enhancer from c-Ki-ras p21 but not from c-raf-1 kinase in NIH3T3 cells.
    Sakoda T, Kaibuchi K, Kishi K, Kishida S, Doi K, Hoshino M, Hattori S, Takai Y.
    Oncogene; 1992 Sep 28; 7(9):1705-11. PubMed ID: 1323817
    [Abstract] [Full Text] [Related]

  • 5. G2A is an oncogenic G protein-coupled receptor.
    Zohn IE, Klinger M, Karp X, Kirk H, Symons M, Chrzanowska-Wodnicka M, Der CJ, Kay RJ.
    Oncogene; 2000 Aug 10; 19(34):3866-77. PubMed ID: 10951580
    [Abstract] [Full Text] [Related]

  • 6. An essential role for Rac in Ras transformation.
    Qiu RG, Chen J, Kirn D, McCormick F, Symons M.
    Nature; 1995 Mar 30; 374(6521):457-9. PubMed ID: 7700355
    [Abstract] [Full Text] [Related]

  • 7. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
    Crespo P, Bustelo XR, Aaronson DS, Coso OA, Lopez-Barahona M, Barbacid M, Gutkind JS.
    Oncogene; 1996 Aug 01; 13(3):455-60. PubMed ID: 8760286
    [Abstract] [Full Text] [Related]

  • 8. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
    Cuadrado A, Bruder JT, Heidaran MA, App H, Rapp UR, Aaronson SA.
    Oncogene; 1993 Sep 01; 8(9):2443-8. PubMed ID: 8361757
    [Abstract] [Full Text] [Related]

  • 9. R-Ras is regulated by activators and effectors distinct from those that control Ras function.
    Huff SY, Quilliam LA, Cox AD, Der CJ.
    Oncogene; 1997 Jan 16; 14(2):133-43. PubMed ID: 9010215
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C, Fernandez-Medarde A, Rojas JM, Font de Mora J, Esteban LM, Santos E.
    Oncogene; 1998 Feb 05; 16(5):613-24. PubMed ID: 9482107
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cooperative transformation of NIH3T3 cells by G alpha12 and Rac1.
    Tolkacheva T, Feuer B, Lorenzi MV, Saez R, Chan AM.
    Oncogene; 1997 Aug 07; 15(6):727-35. PubMed ID: 9264413
    [Abstract] [Full Text] [Related]

  • 15. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins.
    Movilla N, Crespo P, Bustelo XR.
    Oncogene; 1999 Oct 21; 18(43):5860-9. PubMed ID: 10557073
    [Abstract] [Full Text] [Related]

  • 16. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM, Pegg AE.
    Cancer Res; 1998 Jul 01; 58(13):2748-53. PubMed ID: 9661886
    [Abstract] [Full Text] [Related]

  • 17. PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase.
    Cacace AM, Ueffing M, Philipp A, Han EK, Kolch W, Weinstein IB.
    Oncogene; 1996 Dec 19; 13(12):2517-26. PubMed ID: 9000126
    [Abstract] [Full Text] [Related]

  • 18. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J, Jiang B, Coffey RJ, Barnard J.
    Mol Cancer Res; 2004 Apr 19; 2(4):233-41. PubMed ID: 15140945
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synergistic activation of c-fos promoter activity by Raf and Ral GDP dissociation stimulator.
    Okazaki M, Kishida S, Hinoi T, Hasegawa T, Tamada M, Kataoka T, Kikuchi A.
    Oncogene; 1997 Feb 06; 14(5):515-21. PubMed ID: 9053849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.